GST, part of anacura, acquired by Boehringer Ingelheim
2020-07-27
GST, the stem cell specialist for horses and pets within the anacura Group, has been acquired by Boehringer Ingelheim. The acquisition follows two years of successful cooperation. Research and production will continue in anacura’s labs, close to Ghent, Belgium. The current management and staff will play a crucial role in the implementation and further development of stem cell technology within Boehringer Ingelheim.